These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37955780)

  • 1. LncFASA promotes cancer ferroptosis via modulating PRDX1 phase separation.
    Fan X; Liu F; Wang X; Wang Y; Chen Y; Shi C; Su X; Tan M; Yan Q; Peng J; Shao J; Xiong Y; Lin A
    Sci China Life Sci; 2024 Mar; 67(3):488-503. PubMed ID: 37955780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POU2F2-mediated upregulation of lncRNA
    Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
    Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
    Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
    Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
    Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
    Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
    Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
    Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
    Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
    Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells.
    Wen Y; Chen H; Zhang L; Wu M; Zhang F; Yang D; Shen J; Chen J
    Free Radic Biol Med; 2021 Sep; 173():41-51. PubMed ID: 34271106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer.
    Xiang S; Yan W; Ren X; Feng J; Zu X
    Cell Mol Biol Lett; 2024 Mar; 29(1):40. PubMed ID: 38528461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1/miR-214-3p/GPX4.
    He GN; Bao NR; Wang S; Xi M; Zhang TH; Chen FS
    Drug Des Devel Ther; 2021; 15():3965-3978. PubMed ID: 34566408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis.
    Wang Z; Chen X; Liu N; Shi Y; Liu Y; Ouyang L; Tam S; Xiao D; Liu S; Wen F; Tao Y
    Mol Ther; 2021 Jan; 29(1):263-274. PubMed ID: 33002417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARHGAP6 Suppresses Breast Cancer Tumor Growth by Promoting Ferroptosis via RhoA-ROCK1-p38 MAPK Signaling.
    Chen X; Zhu J; Li X; Chen J; Zhou Z; Fan X; Liang R; Liu H; Zhu D
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):6. PubMed ID: 38287795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
    Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
    Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
    J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
    Li J; He D; Li S; Xiao J; Zhu Z
    Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
    J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
    Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
    Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
    Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R
    Cancer Biol Ther; 2023 Dec; 24(1):2223377. PubMed ID: 37370246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anticancer property of
    DU X; Zhang J; Liu L; Xu B; Han H; Dai W; Pei X; Fu X; Hou S
    J Zhejiang Univ Sci B; 2022 Apr; 23(4):286-299. PubMed ID: 35403384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
    Guo QJ; Mills JN; Bandurraga SG; Nogueira LM; Mason NJ; Camp ER; Larue AC; Turner DP; Findlay VJ
    Breast Cancer Res; 2013; 15(4):R70. PubMed ID: 23971998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.